Vaughan Nelson Investment Management, L.P. Coherus Bio Sciences, Inc. Call Options Transaction History
Vaughan Nelson Investment Management, L.P.
- $10.3 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding CHRS
# of Institutions
124Shares Held
64.5MCall Options Held
96.6KPut Options Held
65.3K-
Black Rock Inc. New York, NY11.8MShares$10.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$9.93 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.68 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.54 Million0.27% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.7 Million0.11% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $69.2M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...